ADMA BIOLOGICS, INC. Amortization
ADMA BIOLOGICS, INC. (ADMA) reported Amortization of $200.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2021-05-12
- ADMA BIOLOGICS, INC. amortization for the quarter ending 2021-03-31 was $200.00K, a 0.00% change year-over-year.
- ADMA BIOLOGICS, INC. amortization for the quarter ending 2020-03-31 was $200.00K.
| Period end | Amortization 3 month |
|---|---|
| 2021-03-31 | $200.00K 10-Q · filed 2021-05-12 |
| 2020-03-31 | $200.00K 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |